Lympro launch, MANF RP approved for FDA Orphan, p

Lympro launch, MANF RP approved for FDA Orphan, plus a 2nd Orphan indication application submitted, plus Eltoprazine phase IIb trial set to begin early 2015, plus ESS acquisition to close 4th quarter 2014, plus LP-002 number to be released 4th quarter 2014. Yes, I would say that Gerald is delivering! The AMBS team worked on DD regarding ESS for nearly two years, and not a peep was uttered by anyone. I wonder what other surprises Gerald and the AMBS BOD and BOA have in store???? Another interesting question is the subject of "naked shorts". Is there a position out there, and if so how large????I think we may get the answer today. If there is a naked short position, we could see an incredible scramble today to cover!! Best wishes my fellow AMBS longs. Fasten your seat belts, we are approaching rotation and lift off!